CAS 932372-01-5

Asapiprant

CAS : 932372-01-5

Formule : C₂₄H₂₇N₃O₇S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 501.5521

Ref: IN-DA01E5VD

2-(5-(4-((4-Isopropoxyphenyl)Sulfonyl)Piperazin-1-Yl)-2-(Oxazol-2-Yl)Phenoxy)Acetic Acid

CAS : 932372-01-5

2-(5-(4-((4-Isopropoxyphenyl)Sulfonyl)Piperazin-1-Yl)-2-(Oxazol-2-Yl)Phenoxy)Acetic Acid

Degré de pureté : 98%

Masse moléculaire : 501.55g/mol

Ref: 54-OR1023232

Asapiprant

CAS : 932372-01-5

Asapiprant

Degré de pureté : ≥98%

Masse moléculaire : 501.55g/mol

Ref: 54-BUP09040

Asapiprant

CAS : 932372-01-5

Asapiprant (S-555739) is a potent and selective DP1 receptor antagonist (Ki: 0.44 nM). It exhibited high affinity and selectivity for the DP1 receptor.

Formule : C₂₄H₂₇N₃O₇S

Degré de pureté : 99.64%

Couleur et forme : Solid

Masse moléculaire : 501.55

Ref: TM-T5386

Asapiprant

CAS : 932372-01-5

Asapiprant is a metabolic product of the drug asacol. It has been shown to have anti-inflammatory effects and has been used in studies to determine its efficacy in treating humans infected with covid-19 pandemic. Asapiprant has also been shown to be an effective diagnostic agent for detecting the presence of eicosanoids in nasal fluid. This compound has not yet been tested on animals or humans.

Formule : C₂₄H₂₇N₃O₇S

Degré de pureté : Min. 95%

Masse moléculaire : 501.55 g/mol

Ref: 3D-HMB37201